WESSON BRUCE F 4
4 · ACURA PHARMACEUTICALS, INC · Filed Jan 6, 2021
Insider Transaction Report
Form 4
WESSON BRUCE F
Director
Transactions
- Exercise/Conversion
Common Stock
2021-01-04+54,790→ 658,716 total - Exercise/Conversion
Restricted Stock Units (2017 Plan)
2021-01-04−54,790→ 0 total→ Common Stock (54,790 underlying)
Footnotes (6)
- [F1]Represents exchange of restricted stock units.
- [F2]Par value of $.01 per share must be paid by Reporting Person upon exchange of Restricted Stock Units for stock
- [F3]Does not include Restricted Stock Units.
- [F4]1 - for - 1
- [F5]54,790 Restricted Stock Units were granted on the first business day of January 2020. 25% of Restricted Stock Units vested on March 31, 2020, 25% vested on June 30, 2020; 25% vested on September 30, 2020 and 25% vested on December 31, 2020. Restricted Stock Units are being exchanged on a one for one basis for common stock, in each case upon payment of par value.
- [F6]N/A